Sunrest Lifescience Ltd Share Price

Summary

Sunrest Lifescience Limited was originally incorporated as Sunrest Lifescience Private Limited as a Private Limited Company vide Certificate of Incorporation dated October 30, 2017, issued by the Registrar of Companies, Ahmedabad, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to Sunrest Lifescience Limited. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company was issued by the Registrar of Companies, Ahmedabad on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company has acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital. The Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- eac
Read More